ha 1004 has been researched along with ouabain in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Evans, DB; Harris, AL; Lemp, BM; Silver, PJ | 1 |
Dohi, T; Minami, N; Miyasako, T; Morita, K; Suemitsu, T | 1 |
2 other study(ies) available for ha 1004 and ouabain
Article | Year |
---|---|
The vasorelaxant effects of milrinone and other vasodilators are attenuated by ouabain.
Topics: Animals; Aorta, Thoracic; Colforsin; Drug Interactions; Female; Guinea Pigs; Hydralazine; In Vitro Techniques; Isoproterenol; Isoquinolines; Isosorbide; Milrinone; Nitroprusside; Ouabain; Pyridones; Sodium-Potassium-Exchanging ATPase; Sulfonamides; Vasodilator Agents; Verapamil | 1988 |
Cyclic AMP enhances acetylcholine (ACh)-induced ion fluxes and catecholamine release by inhibiting Na+, K(+)-ATPase and participates in the responses to ACh in cultured bovine adrenal medullary chromaffin cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Acetylcholine; Adrenal Medulla; Animals; Calcium; Catecholamines; Cattle; Cells, Cultured; Colforsin; Cyclic AMP; Enzyme Inhibitors; Isoquinolines; Membrane Potentials; Ouabain; Protein Kinase Inhibitors; Receptors, Cholinergic; Sodium; Sodium-Potassium-Exchanging ATPase; Sulfonamides; Tetrodotoxin; Thionucleotides | 1995 |